🔎 Trials Near Me

Akèy › Kolit Ulseratif › Texas › Lewisville

Etid klinik pou Kolit Ulseratif nan Lewisville, TX

10 etid pou Kolit Ulseratif ap chèche patisipan nan sit nan ak bò kote Lewisville (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)

Ap rekriteFaz 3
  • GI Alliance - Southlake ( Site 0298), Southlake · 11 mi lwen
Tout laj · Tout sèks · Mizajou Oct 2, 2026 · NCT06651281

Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis

Ap rekriteFaz 2
  • Texas Digestive Disease Consultants - Southlake /ID# 283931, Southlake · 11 mi lwen
Laj 18 a 75 · Tout sèks · Mizajou Oct 2, 2026 · NCT07697456

A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis

Ap rekriteFaz 2
  • Site 008, Southlake · 11 mi lwen
Laj 18 a 75 · Tout sèks · Mizajou Sep 29, 2026 · NCT07012395

A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis

Ap rekriteFaz 2
  • Site US-001, Southlake · 11 mi lwen
Laj 18 a 75 · Tout sèks · Mizajou Sep 29, 2026 · NCT07845487

A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis

Ap rekriteFaz 3
  • GI Alliance Southlake, Southlake · 11 mi lwen
Laj 12 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT07196748

A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)

Ap rekriteFaz 4
  • Texas Digestive Disease Consultants (TDDC), Southlake, Southlake · 11 mi lwen
Laj 18 a 65 · Tout sèks · Mizajou Sep 21, 2026 · NCT06095128

A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis

Ap rekriteFaz 3
  • Texas Digestive Disease Consultants, PLLC. dba GI Alliance - Southlake - Corporate Office - Site Number: 8400101, Southlake · 11 mi lwen
Laj 16 a 80 · Tout sèks · Mizajou Sep 15, 2026 · NCT07185009

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis

Ap rekriteFaz 3
  • Texas Digestive Disease Consultants, PLLC. dba GI Alliance - Southlake - Site Number: 8400101, Southlake · 11 mi lwen
Laj 16 a 80 · Tout sèks · Mizajou Aug 20, 2026 · NCT07184996

An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis

Ap rekriteEtid obsèvasyon
  • GI Alliance Research, Southlake · 11 mi lwen
Laj 18 a 64 · Tout sèks · Mizajou Jul 9, 2026 · NCT06398626

A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease

Ap rekriteFaz 2
  • Mirador Therapeutics Selected Site, Southlake · 11 mi lwen
Laj 18 a 80 · Tout sèks · Mizajou Mar 12, 2026 · NCT07113522

Etid Kolit Ulseratif nan lòt vil

Lòt etid nan Lewisville

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.